Navigation Links
AGM / EGM Postponed to July 20, 2008
Date:7/17/2008

VALLEY COTTAGE, N.Y., July 17 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) announces that the Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") scheduled for today were adjourned and postponed until Sunday, July 20, 2008 at 4:00pm and 4:30 pm Israel time, respectively.

ABOUT XTL BIOPHARMACEUTICALS LTD.

XTL Biopharmaceuticals Ltd. ("XTL") is engaged in the development of therapeutics for the treatment of diabetic neuropathic pain and HCV. XTL is developing Bicifadine, a serotonin and norepinephrine reuptake inhibitor, for the treatment of diabetic neuropathic pain, which is currently in a Phase 2b study. XTL has out-licensed its novel pre-clinical HCV small molecule inhibitor program. XTL also has an active in-licensing and acquisition program designed to identify and acquire additional drug candidates. XTL is publicly traded on the NASDAQ and Tel-Aviv Stock Exchanges (Nasdaq: XTLB; TASE: XTL).


'/>"/>
SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... 23, 2017  Recognizing the need to grow ... and solutions, the University of Miami announced Monday ... Science and Engineering to achieve those milestones by ... help solve some of the world,s most pressing ... Julio Frenk unveiled the network of intertwined ...
(Date:1/24/2017)... ANGELES , Jan. 23, 2017   Instrument ... Bio-Techne ( Minneapolis, MN ) the ... is the most authoritative newsletter tracking developments in ... market. "Bio-Techne consistently achieved outstanding technical, ... Tanya Samazan, Managing Editor of IBO. "In 2016, ...
(Date:1/24/2017)... MONTREAL , Jan. 23, 2017 /PRNewswire/ - BioAmber Inc. ... has entered into an underwriting agreement with Rodman & ... Co., LLC, as sole book running manager and representative of ... purchase on a firm commitment basis a minimum of ... with warrants to purchase a minimum of 1,052,632 shares ...
(Date:1/23/2017)... -- Spherix Incorporated (Nasdaq: SPEX ) an intellectual ... and monetization of intellectual property, today provided an update ... Anthony Hayes , Chief Executive Officer of Spherix, stated, ... with shareholders about the status of existing monetization efforts ... patent assets that fit with our current holdings.  We ...
Breaking Biology Technology:
(Date:12/20/2016)... RALEIGH, N.C. and GENEVA, Dec, 20, 2016 ... performance biometric data sensor technology, and STMicroelectronics ... across the spectrum of electronics applications, announced today ... scalable development kit for biometric wearables that includes ... integrated with Valencell,s Benchmark™ biometric sensor ...
(Date:12/15/2016)... and BADEN-BADEN, Germany , December ... leading global financial services provider, today announced an agreement with ... behavioural biometrics, to join forces. The partnership will enable clients ... strategies in compliance with local data protection regulation. ... In order to ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the ... market is expected to grow from USD 4.03 billion ... a CAGR of 29.3% between 2016 and 2022. The ... demand for smart devices, government initiatives, and increasing penetration ... is expected to grow at a high rate during ...
Breaking Biology News(10 mins):